These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1532940)

  • 21. Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD.
    Viegas CA; Ferrer A; Montserrat JM; Barberà JA; Roca J; Rodriguez-Roisin R
    Chest; 1996 Jul; 110(1):71-7. PubMed ID: 8681669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent).
    Packe GE; Archer PS; Cayton RM
    Postgrad Med J; 1984; 60 Suppl 1():18-22. PubMed ID: 6233546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Domiciliary nebulized terbutaline in severe chronic airways obstruction.
    Hansen NC; May O
    Eur Respir J; 1990 Apr; 3(4):463-4. PubMed ID: 2365041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
    Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action.
    McIntosh D
    Pharmatherapeutica; 1986; 4(7):416-21. PubMed ID: 2938194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation.
    Jenkins SC; Heaton RW; Fulton TJ; Moxham J
    Chest; 1987 Jun; 91(6):804-7. PubMed ID: 3556051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy.
    Congleton J; Muers MF
    Respir Med; 1995 Apr; 89(4):291-6. PubMed ID: 7597269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long-term study of symptoms, spirometry and survival amongst home nebulizer users.
    O'Driscoll BR; Bernstein A
    Respir Med; 1996 Oct; 90(9):561-6. PubMed ID: 8984531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation.
    Mitchell DM; Gildeh P; Dimond AH; Collins JV
    Thorax; 1986 Aug; 41(8):606-10. PubMed ID: 3538487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD).
    Poole PJ; Brodie SM; Stewart JM; Black PN
    Aust N Z J Med; 1998 Jun; 28(3):322-6. PubMed ID: 9673744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A long-term prospective assessment of home nebulizer treatment.
    O'Driscoll BR; Kay EA; Taylor RJ; Weatherby H; Chetty MC; Bernstein A
    Respir Med; 1992 Jul; 86(4):317-25. PubMed ID: 1448587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to oral corticosteroids in chronic airflow obstruction.
    Lam WK; So SY; Yu DY
    Br J Dis Chest; 1983 Apr; 77(2):189-98. PubMed ID: 6347233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of nebulized bronchodilators in infants under 1 year of age: analysis of four forms of therapy.
    Mallol J; Barrueto L; Girardi G; Muñoz R; Puppo H; Ulloa V; Toro O; Quevedo F
    Pediatr Pulmonol; 1987; 3(5):298-303. PubMed ID: 2959900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of a new breath-actuated inhaler by patients with severe airflow obstruction.
    Fergusson RJ; Lenney J; McHardy GJ; Crompton GK
    Eur Respir J; 1991 Feb; 4(2):172-4. PubMed ID: 2044733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of prednisolone in chronic airflow limitation.
    Mitchell DM; Gildeh P; Rehahn M; Dimond AH; Collins JV
    Lancet; 1984 Jul; 2(8396):193-6. PubMed ID: 6146752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nebulized ipratropium bromide in ventilator-assisted patients with chronic bronchitis.
    Yang SC; Yang SP; Lee TS
    Chest; 1994 May; 105(5):1511-5. PubMed ID: 8181345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment.
    Mitchell DM; Gildeh P; Rehahn M; Dimond A; Collins JV
    Thorax; 1984 Dec; 39(12):924-7. PubMed ID: 6393417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical response to nebulized ipratropium bromide in pre-term infants asymptomatic at follow-up.
    Yuksel B; Greenough A; Green S
    Respir Med; 1991 May; 85(3):189-94. PubMed ID: 1831916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of lung function and postnatal age on the response to nebulized ipratropium bromide in children born prematurely.
    Yüksel B; Greenough A
    Respir Med; 1994 Aug; 88(7):527-30. PubMed ID: 7972978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.